Morris Miller, CEO of Xenex Disinfection Services talks about hospital-acquired infections (HAIs) and the Xenex® LightStrike™ Germ-Zapping™ Robot that is proven to kill superbugs like MRSA and C. diff on high touch surfaces.
Nearly 300 people die in the U.S. every day from an infection they acquired during their hospital stay. Many of the superbugs (like C.diff and MRSA) that cause infections have become resistant to antibiotics, cleaning chemicals, and hand sanitizers. Xenex’s mission is to stop the pain and suffering caused in healthcare-associated infections by destroying the pathogens that cause them. Under Morris Miller’s leadership, Xenex has become a world leader in automated room disinfection. Through the use of pulsed xenon UV technology and innovative hospital disinfection protocols, the company has helped hospitals achieve significant infection reduction results. As CEO, Morris is responsible for the company’s overall business strategy and oversight of day-to-day operations. Originally from San Antonio, Morris is a graduate of the Dedman School of Law at Southern Methodist University, The University of Texas at Austin, and Phillips Exeter Academy. He is the co-founder of Tectonic Ventures which was formed in 2016 to invest in and advise founders, startups and established technology companies. Prior to co-founding Tectonic Ventures, Morris founded Sequel Ventures, LLC and Cutstone Ventures, LLC which invest in/act as advisors to numerous start-ups such as Inventables, Adometry, and Golfballs.com. Previously, Morris started Curtis Hill Publishing, the first company to publish Texas case law on CD-ROM. He co-founded Rackspace Managed Hosting where he acted as Managing Director and Co-Chairman (NYSE: RAX). Morris is a member of APIC and BioMed SA.